Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients

por ElBaiomy, M. A., Aref, S., El Zaafarany, M., Atwa, Sara, Akl, Tamer, El-Beshbishi, Wafaa, El-Ashwah, Shaimaa, Ibrahim, L., El-Ghonemy, M.
Publicado 2019